Dr. Mohamed E. Taha, MD

Dr. Taha practices at Texan Cardiovascular Institute, PA in El Paso, Texas.

Dr. Taha's NPI, 1407217300, was assigned on March 19, 2016. Dr. Taha graduated from University of Khartoum Faculty of Medicine in 2010. Dr. Taha holds Virginia license 0101274232.

Dr. Taha's primary practice is Texan Cardiovascular Institute, PA, at 1840 Joe Battle Blvd, El Paso, TX 79936 in El Paso County. The practice phone is (915) 249-4344.

Dr. Taha's primary practice is Texan Cardiovascular Institute, PA in El Paso, Texas. Dr. Taha is also affiliated with Las Palmas Medical Center. The medical group on file is Sentara Medical Group. Dmand AI also links Dr. Taha to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taha practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Taha's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Taha is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Taha's licenses on file in 7 states: Virginia, Texas, District of Columbia, Iowa, California, Nevada and Wisconsin.

CMS data shows 20 Medicare services from Dr. Taha across 1 procedure code in 2024, for 29 Medicare patients. Medicare paid $1,202 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Taha in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taha's median patient age at 71, with 49% women.

In 2023, Dr. Taha wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $185 in total drug cost. In 2022, CMS named 93 claims across 4 drugs.

Dr. Taha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Taha, published from 2018 to 2023. 2018 was the busiest year, with 9. The most frequent topics are Aortic Valve Stenosis, Atrial Fibrillation and Heart Failure. Dr. Taha has published most often in Cureus. Dr. Taha's most frequent co-authors are Rajkumar Prakashbhai Doshi, MD, Mark Bilinyi Ulanja, MD and Santhosh Ambika, MD.

CMS Open Payments shows 104 general payments to Dr. Taha from 19 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 43% of the total. Medtronic, Inc. paid the most, $2,406.

Dr. Taha graduated from University of Khartoum Faculty of Medicine in 2010.

Dr. Taha is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.